Barriers Rural Physicians Face Prescribing Buprenorphine for Opioid Use Disorder
| Autor: | Eric H. Larson, C. Holly A. Andrilla, Cynthia Coulthard |
|---|---|
| Rok vydání: | 2017 |
| Předmět: |
Adult
Male medicine.medical_specialty 030508 substance abuse Drug Prescriptions 03 medical and health sciences 0302 clinical medicine Agency (sociology) Opiate Substitution Treatment medicine Humans 030212 general & internal medicine Practice Patterns Physicians' health care economics and organizations Aged Drug enforcement Research Briefs business.industry Rural health Public health Opioid use disorder Middle Aged Opioid-Related Disorders medicine.disease Waiver United States Buprenorphine Anesthesia Family medicine Female Rural Health Services 0305 other medical science Family Practice business medicine.drug |
| Zdroj: | The Annals of Family Medicine. 15:359-362 |
| ISSN: | 1544-1717 1544-1709 |
| Popis: | Opioid use disorder is a serious public health problem. Management with buprenorphine is an effective, office-based, medication-assisted treatment, but 60.1% of rural counties in the United States lack a physician with a Drug Enforcement Agency waiver to prescribe buprenorphine. This national study surveyed all rural physicians who have received a waiver in the United States and found that those who were not actively prescribing buprenorphine reported significantly more barriers than those who were, regardless of whether they were treating the maximum number of patients their waiver allowed. These findings suggest the need for tailored strategies to address barriers to providing buprenorphine for opioid use disorder and to support physicians who are adding or maintaining this service. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|